← All indications
Rotavirus Infections
Infection with any of the rotaviruses. Specific infections include human infantile diarrhea, neonatal calf diarrhea, and epidemic diarrhea of infant mice.
Drugs by status
Approved for this indication (3)
Phase 4 trials (11)
- yellow fever vaccine 17d strain
- attenuated measles vaccine - Edmonston strain
- measles-rubella vaccine
- acellular pertussis vaccine (including diptheria and tetanus toxoids)
- monovalent group c meningococcal vaccine
- polio, inactivated poliovirus vaccine
- zinc
- lactobacillus reuteri
- lactobacillus rhamnosus
- polymethylsiloxane
- Inactivated polio virus - Enhanced
Phase 3 trials (20)
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- nitazoxanide
- pneumococcal 13-valent conjugate vaccine
- acetaminophen
- multi-valent pneumococcal conjugate vaccine
- inactivated poliovirus type 2 vaccine
- anti-rotavirus protein
- Haemophilus influenzae Type b Conjugate and Hepatitis B (Recombinant)
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- 10-valent Pneumococcal Conjugate Vaccine
- dipropyltryptamine
- brv-pv
- haemophilus influenzae type b conjugate vaccine
- bivalent oral polio vaccine (bopv), type 1 and type 3
- diphtheria toxoid
- matrix m1
- tv p2-vp8
- rotavin
- rotavirus rv3 vaccine
- Monovalent group C meningococcal vaccine
Phase 2 trials (8)
Organizations
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (12)
- Sanofi-Aventis
- Romark
- Bharat Biotech International Limited
- Cairo University
- University of Ghana
- Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
- Vietnam Military Medical University
- University of Malawi
- Bill and Melinda Gates Foundation
- PATH
- SK Bioscience Co., Ltd.
- Centre for Infectious Disease Research in Zambia (CIDRZ)
Organization Involved with Phase 2 Indications (5)
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (3)